180 related articles for article (PubMed ID: 18569331)
1. In vitro aldose reductase inhibitory activity of some flavonyl-2,4-thiazolidinediones.
Daş-Evcimen N; Bozdağ-Dündar O; Sarikaya M; Ertan R
J Enzyme Inhib Med Chem; 2008 Jun; 23(3):297-301. PubMed ID: 18569331
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and aldose reductase inhibitory activity of some new chromonyl-2,4-thiazolidinediones.
Bozdağ-Dündar O; Evranos B; Daş-Evcimen N; Sarikaya M; Ertan R
Eur J Med Chem; 2008 Nov; 43(11):2412-7. PubMed ID: 18313804
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of some new flavonyl-2,4-thiazolidinediones.
Bozdağ-Dündar O; Verspohl EJ; Daş-Evcimen N; Kaup RM; Bauer K; Sarikaya M; Evranos B; Ertan R
Bioorg Med Chem; 2008 Jul; 16(14):6747-51. PubMed ID: 18565754
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors.
Sambasivarao SV; Soni LK; Gupta AK; Hanumantharao P; Kaskhedikar SG
Bioorg Med Chem Lett; 2006 Feb; 16(3):512-20. PubMed ID: 16297625
[TBL] [Abstract][Full Text] [Related]
5. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase.
Huang W; Zhang Y; Liang X; Yang L
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900371. PubMed ID: 32237167
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR studies on a series of 5-arylidine-2, 4-thiazolidinediones as aldose reductase inhibitors: a self-organizing molecular field analysis approach.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Med Chem; 2010 Jan; 6(1):30-6. PubMed ID: 20402658
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
8. CoMFA and CoMSIA analysis of 2,4-thiazolidinediones derivatives as aldose reductase inhibitors.
Liu HY; Liu SS; Qin LT; Mo LY
J Mol Model; 2009 Jul; 15(7):837-45. PubMed ID: 19132416
[TBL] [Abstract][Full Text] [Related]
9. Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney.
Demir Y; Işık M; Gülçin İ; Beydemir Ş
J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28557170
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of Isoflavones isolated from Caesalpinia pulcherrima on aldose reductase in STZ induced diabetic rats.
Kumar MP; Sankeshi V; Naik RR; Thirupathi P; Das B; Raju TN
Chem Biol Interact; 2015 Jul; 237():18-24. PubMed ID: 25986969
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol.
Sampath C; Sang S; Ahmedna M
Biomed Pharmacother; 2016 Dec; 84():502-513. PubMed ID: 27685794
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.
Iqbal Z; Morahan G; Arooj M; Sobolev AN; Hameed S
Eur J Med Chem; 2019 Apr; 168():154-175. PubMed ID: 30818176
[TBL] [Abstract][Full Text] [Related]
14. Highly selective aldose reductase inhibitors. II. Optimization of the aryl part of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
Kotani T; Ishii A; Nagaki Y; Toyomaki Y; Yago H; Suehiro S; Okukado N; Okamoto K
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):297-304. PubMed ID: 9118444
[TBL] [Abstract][Full Text] [Related]
15. Inhibition effects of quinones on aldose reductase: Antidiabetic properties.
Demir Y; Özaslan MS; Duran HE; Küfrevioğlu Öİ; Beydemir Ş
Environ Toxicol Pharmacol; 2019 Aug; 70():103195. PubMed ID: 31125830
[TBL] [Abstract][Full Text] [Related]
16. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.
Maccari R; Del Corso A; Giglio M; Moschini R; Mura U; Ottanà R
Bioorg Med Chem Lett; 2011 Jan; 21(1):200-3. PubMed ID: 21129963
[TBL] [Abstract][Full Text] [Related]
19. Aldose reductase inhibitors from the nature.
Kawanishi K; Ueda H; Moriyasu M
Curr Med Chem; 2003 Aug; 10(15):1353-74. PubMed ID: 12871134
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
